Owner, Director and CEO, KaRa Institute of Neurological Diseases (KaRa MINDS)
A/Prof Kathryn Goozee is the founder, owner, Director and CEO of the KaRa Institute of Neurological Diseases (KaRa MINDS), an independent clinical trials centre and memory clinic established in 2014 in Macquarie Park, Sydney. Recognised as a leader in dementia research and clinical care, she oversees a multidisciplinary team of approximately 20 clinicians and researchers delivering pharmaceutical clinical trials across healthy ageing, mild cognitive impairment and Alzheimer’s disease cohorts. Her team has built a strong reputation for successful recruitment and high-quality research delivery.
An Honorary Associate Professor in the Faculty of Medicine, Health and Human Sciences at Macquarie University, Kathryn completed a PhD in Alzheimer’s research at the University of Western Australia in 2023 and serves as a Principal Investigator with the Australian Dementia Network and other studies. She brings broad experience in dementia care, including senior roles as a Director of Nursing, Clinical Nurse Consultant, Manager of dementia community services and respite facilities. An innovator in service delivery, she focuses on translating research findings into clinical practice. In 2008, she became one of the first nurse practitioners specialising in dementia to practise in residential care. She has authored more than 40 original journal articles and is a respected community speaker on dementia research translation, prevention, detection and care.
Kathryn is a non-executive board member of Scalabrini Community Ltd, a volunteer committee member of the Dementia Research Community, and an invited member of the leadership group within the Dementia Research Centre (Brain Institute and Clinic). Her professional memberships include the Australian Association of Gerontology, Dementia Australia, the International Society to Advance Alzheimer’s Research and Treatment, the Australian College of Nursing, and the Australian College of Nurse Practitioners.